InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Astor Andrew, Chief Executive Officer. Director active across 1 companies, notably NEPHROS INC. Aggregated, 3 filings have been published. Total volume traded: €33k. The latest transaction was disclosed on 5 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€36,14414,815 shares@ €2.43970.070% mcap52.5% of flow
Common Stock
SEC:0001437749-22-005408:0·
€16,3722,500 shares@ €6.5490.032% mcap100.0% of flow
Common Stock
SEC:0000914190-21-000282·
Ideal exit: 14 May 2022 (T+270)
€16,3722,500 shares@ €6.5490.032% mcap23.8% of flow
Common Stock
SEC:0000914190-21-000282:0·
Ideal exit: 14 May 2022 (T+270)
3 of 3 declarations
About Astor Andrew
Andrew Astor is the President and CEO of Nephros Inc. He oversees the company's operations and strategy, focusing on innovation in water purification technologies. His role is crucial in ensuring growth and development of public health solutions.
